Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Lucid Group Inc (LCID) vs Nuwellis Inc (NUWE) Price & Performance

Lucid Group IncTrade
Nuwellis IncTrade

Price performance (Past 24H)

Key statistics

Lucid Group Inc vs Nuwellis Inc — how do they compare? Lucid Group Inc trades at $6.72 (market cap $2.60B), while Nuwellis Inc trades at $1.48 (market cap $522.76K). The key difference: Lucid Group Inc is far larger — about 4973.6× Nuwellis Inc's market cap, and Lucid Group Inc is trading nearer its 52-week high, Nuwellis Inc nearer its low. Which is the better fit depends on your goals.

LCIDNUWE
Market Cap
$2.60B$522.76K
Sector
Consumer CyclicalTechnology
52-Week High
$24.77$220.50
52-Week Low
$4.62$1.42
Enterprise Value
$5.50B-$1.29M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Lucid Group Inc

No Aura AI signal available yet.

Nuwellis Inc

NUWE trades at $1.49, down 8.59% over the past day, with a bearish technical outlook. The company reported a net loss of $17.52M in 2025, with a negative net income margin of -217.22%, though it has shown revenue growth and recent strategic expansions in pediatric care. A recent 35:1 reverse stock split was executed on June 26, 2026.

The outlook remains high-risk due to persistent losses and cash burn, but growth initiatives and new product development offer potential. Key risks include execution challenges and dependence on financing. Analyst sentiment is mixed, with a 50% buy and 50% hold rating among covered analysts.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Lucid Group Inc

Lucid Group Inc is a technology and automotive company. It develops the next generation of electric vehicle (EV) technologies. It is a vertically integrated company that designs, engineers, and builds electric vehicles, EV powertrains, and battery systems in-house using our own equipment and factory.

Read more on LCID

About Nuwellis Inc

Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.

Read more on NUWE